Migraine Headache Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Abortive Medicine, and Preventive Medicine); Route of Administration (Oral, Injection, and Others); Distribution Channel (Hospital-based Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography
Migraine is a clinical condition accompanying painful headaches and other symptoms such as nausea, sensitivity to smell, increased sensitivity to light, increased sensitivity to sound, tingling or numbness in the extremities or legs, sweating, and diarrhea. These headaches usually occur on one side of the head, and each episode of migraine has a different duration and intensity. Migraine drugs are used in the treatment of headaches associated with migraines. Migraines are more frequent in women compared to men.
The "Global Migraine headache drugs Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Migraine headache drugs market with detailed market segmentation by type, route of administration, distribution channel, and geography. The report provides key statistics on the market status of the leading Migraine headache drugs market players and offers key trends and opportunities in the market.
- Based on type, the global Migraine headache drugs market is segmented into abortive medicine, and preventive medicine. Abortive Medicine is again segmented into triptans (serotonin receptor agonists), ergotamine derivative, others and preventive medicine into anticonvulsant, antidepressant, beta blocker, others.
- On the basis of route of administration, the market is segmented into oral, injection, others.
- On the basis of distribution channel, the market is segmented into hospital-based pharmacies, retail pharmacies, online pharmacies.
MARKET DYNAMICS Drivers:
- Rise in the cases of migraine.
- Rise in the awareness regarding migraine and its treatment.
- Rise in female population.
- The side effects associated with migraine drugs is the major restraining factor for this market.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Migraine headache drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
BThe report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Migraine headache drugs market in these regions.
IMPACT OF COVID-19 ON MIGRAINE HEADACHE DRUGS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Get more information on this report :
The report covers key developments in the Migraine headache drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Migraine headache drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for Migraine headache drugs in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Migraine headache drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott Laboratories
- Allergan Plc.
- Eisai Co., Ltd.
- Endo International Plc.
- GlaxoSmithKline Plc
- Impax Laboratories
- Johnson and Johnson
- Merck and Co.
- Pfizer Inc.
The Insight Partner's dediMigraine headache drugsed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
The List of Companies
1. Abbott Laboratories
2. Allergan Plc.
4. Eisai Co., Ltd.
5. Endo International Plc.
6. GlaxoSmithKline Plc
7. Impax Laboratories
8. Johnson and Johnson
9. Merck and Co.
10. Pfizer Inc.
12. Teva Pharma
13. Eli Lilly